Australia markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
568.72-8.17 (-1.42%)
At close: 04:00PM EDT
568.72 0.00 (0.00%)
After hours: 05:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 217.09B
Enterprise value 245.45B
Trailing P/E 36.48
Forward P/E 26.32
PEG ratio (5-yr expected) 2.83
Price/sales (ttm)5.18
Price/book (mrq)4.77
Enterprise value/revenue 5.78
Enterprise value/EBITDA 21.63

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 33.32%
S&P500 52-week change 323.10%
52-week high 3603.82
52-week low 3415.60
50-day moving average 3573.87
200-day moving average 3530.50

Share statistics

Avg vol (3-month) 31.34M
Avg vol (10-day) 31.66M
Shares outstanding 5381.71M
Implied shares outstanding 6381.71M
Float 8381.11M
% held by insiders 10.18%
% held by institutions 192.18%
Shares short (15 Apr 2024) 42.59M
Short ratio (15 Apr 2024) 42.11
Short % of float (15 Apr 2024) 40.68%
Short % of shares outstanding (15 Apr 2024) 40.68%
Shares short (prior month 15 Mar 2024) 43.43M

Dividends & splits

Forward annual dividend rate 41.56
Forward annual dividend yield 40.27%
Trailing annual dividend rate 31.44
Trailing annual dividend yield 30.25%
5-year average dividend yield 40.22
Payout ratio 49.24%
Dividend date 315 Apr 2024
Ex-dividend date 414 Mar 2024
Last split factor 23:2
Last split date 306 June 1996

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 14.20%
Operating margin (ttm)16.68%

Management effectiveness

Return on assets (ttm)4.82%
Return on equity (ttm)13.62%

Income statement

Revenue (ttm)42.49B
Revenue per share (ttm)110.37
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)N/A
EBITDA 10.78B
Net income avi to common (ttm)6.03B
Diluted EPS (ttm)15.58
Quarterly earnings growth (yoy)3.00%

Balance sheet

Total cash (mrq)7.25B
Total cash per share (mrq)18.98
Total debt (mrq)35.61B
Total debt/equity (mrq)78.05%
Current ratio (mrq)1.70
Book value per share (mrq)119.12

Cash flow statement

Operating cash flow (ttm)8.93B
Levered free cash flow (ttm)6.08B